Contact

All Stories

  1. Computational Methods for Cancer Neoantigen Prediction

    Article • October 2025, Springer Science + Business Media

    Dr Theodora Katsila

  2. Deciphering the Tumor Microenvironment Composition Using Bulk Transcriptomics: A Guide to Recent Advances and Open Challenges

    Article • October 2025, Springer Science + Business Media

    Dr Theodora Katsila

  3. Using Epigenetic Data to Deconvolute Immune Cells in Cancer from Blood Samples

    Article • October 2025, Springer Science + Business Media

    Dr Theodora Katsila

  4. Intepirdine Derivatives Possessing Dual 5HT6 Antagonism / HDAC6 Inhibitory Activity

    Article • Chemistry - A European Journal, August 2025, Wiley

    Dr Theodora Katsila

  5. CAR Exosome-Based Therapeutics

    Article • January 2025, Springer Science + Business Media

    Dr Theodora Katsila

  6. An expert consensus statement on biomarkers of ageing for use in intervention studies

    Article • The Journals of Gerontology Series A, December 2024, Oxford University Press (OUP)

    Dr Theodora Katsila, Professor Lutz Schomburg

  7. AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors

    Article • Journal of Chemical Information and Modeling, November 2024, American Chemical Society (ACS)

    Dr Theodora Katsila

  8. Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC

    Article • Cancers, November 2024, MDPI AG

    Dr Theodora Katsila

  9. Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for OMICS: A Journal of Integrative Biology

    Article • OMICS A Journal of Integrative Biology, September 2024, SAGE Publications

    Dr Theodora Katsila

  10. Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease

    Article • Stem Cell Research & Therapy, July 2024, Springer Science + Business Media

    Dr Theodora Katsila

  11. Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins

    Article • International Journal of Molecular Sciences, May 2024, MDPI AG

    Dr Theodora Katsila

  12. Clinical implementation of preemptive pharmacogenomics in psychiatry

    Article • EBioMedicine, March 2024, Elsevier

    Dr Theodora Katsila

  13. Data-Driven Drug Repurposing in Diabetes Mellitus through an Enhanced Knowledge Graph

    Article • October 2023, MDPI AG

    Dr Theodora Katsila

  14. Cloudscreen: A “one-stop-shop” Platform for Drug Repurposing

    Article • September 2023, ScienceOpen

    Dr Theodora Katsila

  15. A quest for the stereo-electronic requirements for selective agonism for the neurotrophin receptors TrkA and TrkB in 17-spirocyclic-dehydroepiandrosterone derivatives

    Article • Frontiers in Molecular Neuroscience, September 2023, Frontiers

    Dr Theodora Katsila

  16. A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing

    Article • OMICS A Journal of Integrative Biology, July 2023, Mary Ann Liebert Inc

    Dr Theodora Katsila

  17. Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s Disease.

    Article • June 2023, Springer Science + Business Media

    Dr Theodora Katsila

  18. Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s Disease

    Article • May 2023, Cold Spring Harbor Laboratory Press

    Dr Theodora Katsila

  19. Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes

    Article • Metabolites, February 2023, MDPI AG

    Dr Theodora Katsila

  20. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    Article • The Lancet, February 2023, Elsevier

    Dr Theodora Katsila

  21. Development of a multigram synthesis of the bradykinin receptor 2 agonist FR‐190997 and analogs thereof

    Article • Archiv der Pharmazie, January 2023, Wiley

    Dr Theodora Katsila

  22. Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery

    Article • Pharmaceutics, January 2023, MDPI AG

    Dr Theodora Katsila

  23. CAR Exosome-Based Therapeutics

    Article • January 2023, Springer Science + Business Media

    Dr Theodora Katsila

  24. Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean

    Article • OMICS A Journal of Integrative Biology, October 2022, Mary Ann Liebert Inc

    Dr Theodora Katsila

  25. Untargeted Metabolomics for Disease-Specific Signatures

    Article • September 2022, Springer Science + Business Media

    Dr Theodora Katsila

  26. Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications

    Article • Anticancer Research, July 2022, International Institute of Anticancer Research

    Dr Theodora Katsila

  27. Diagnostic and Therapeutic Challenges in a Patient with Ureteral Metastases from a Triple Negative Breast Cancer

    Article • July 2022, MDPI AG

    Dr Theodora Katsila

  28. A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes

    Article • June 2022, MDPI AG

    Dr Theodora Katsila

  29. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries

    Article • PLOS One, June 2022, PLOS

    Dr Theodora Katsila

  30. The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review

    Article • Human Genetics, April 2022, Springer Science + Business Media

    Dr Theodora Katsila

  31. ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses

    Article • Biomolecules, March 2022, MDPI AG

    Dr Theodora Katsila

  32. Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity

    Article • Biomedicines, March 2022, MDPI AG

    Dr Theodora Katsila

  33. Three-Dimensional Cell Metabolomics Deciphers the Anti-Angiogenic Properties of the Radioprotectant Amifostine

    Article • Cancers, June 2021, MDPI AG

    Dr Theodora Katsila

  34. Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology

    Article • International Journal of Molecular Sciences, April 2021, MDPI AG

    Dr Theodora Katsila, Dr VERONIKI VIDALI

  35. Insights into intrauterine growth restriction based on maternal and umbilical cord blood metabolomics

    Article • Scientific Reports, April 2021, Springer Science + Business Media

    Dr Theodora Katsila

  36. Bioenergetic Profiling of the Differentiating Human MDS Myeloid Lineage with Low and High Bone Marrow Blast Counts

    Article • Cancers, November 2020, MDPI AG

    Dr Theodora Katsila

  37. The Metabolomic Status of the Differentiating Myeloid Lineage in MDS with Low and High Bone Marrow Blast Counts

    Article • Blood, November 2020, American Society of Hematology

    Dr Theodora Katsila

  38. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe “PREPARE” study

    Article • Psychiatriki, October 2020, Hellenic Psychiatric Association

    Maria Skokou, Dr Theodora Katsila

  39. The role of microRNAs in gliomas – Therapeutic implications

    Article • Current Molecular Pharmacologye, July 2020, Bentham Science Publishers

    Dr Theodora Katsila

  40. Documentation of clinically relevant genomic biomarker allele frequencies in the next‐generation FINDbase worldwide database

    Article • Human Mutation, April 2020, Wiley

    Dr Theodora Katsila

  41. Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events

    Article • OMICS A Journal of Integrative Biology, April 2020, SAGE Publications

    Dr Theodora Katsila

  42. Challenges in identifying large germline structural variants for clinical use by long read sequencing

    Article • Computational and Structural Biotechnology Journal, January 2020, Elsevier

    Dr Theodora Katsila

  43. VEGF-A and ICAM-1 Gene Polymorphisms as Predictors of Clinical Outcome to First-Line Bevacizumab-Based Treatment in Metastatic Colorectal Cancer

    Article • International Journal of Molecular Sciences, November 2019, MDPI AG

    Dr Theodora Katsila

  44. 4th ESPT Conference: Pharmacogenomics and Personalized Medicine – Research Progress and Clinical Implementation

    Article • Pharmacogenomics, October 2019, Taylor & Francis

    Dr Theodora Katsila

  45. Corrigendum

    Article • Human Mutation, August 2019, Wiley

    Dr Theodora Katsila

  46. Pharmacomicrobiomics informs clinical pharmacogenomics

    Article • Pharmacogenomics, July 2019, Future Medicine

    Dr Theodora Katsila

  47. Genomic Variants in Members of the Krüppel-Like Factor Gene Family are Associated with Disease Severity and Hydroxyurea Treatment Efficacy in β-Hemoglobinopathies Patients

    Article • Pharmacogenomics, July 2019, Taylor & Francis

    Dr Theodora Katsila

  48. A Noninvasive Ocular (Tear) Sampling Method for Genetic Ascertainment of Transgenic Mice and Research Ethics Innovation

    Article • OMICS A Journal of Integrative Biology, June 2019, Mary Ann Liebert Inc

    Dr Theodora Katsila

  49. Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow

    Article • Frontiers in Pharmacology, April 2019, Frontiers

    Dr Theodora Katsila

  50. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis

    Article • Human Mutation, January 2019, Wiley

    Dr Theodora Katsila

  51. Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention

    Article • The Pharmacogenomics Journal, January 2019, Springer Science + Business Media

    Dr Theodora Katsila

  52. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study

    Article • Hemoglobin, January 2019, Taylor & Francis

    Dr Theodora Katsila, George Patrinos, Bassam Ali

  53. Implementation of Genomic Medicine

    Article • January 2019, Elsevier

    Dr Theodora Katsila

  54. Autophagy in Myelodysplastic Syndromes: The Role of HIF-1a/REDD1 Molecular Pathway

    Article • Blood, November 2018, American Society of Hematology

    Dr Theodora Katsila

  55. How far have we come with contextual data integration in drug discovery?

    Article • Expert Opinion on Drug Discovery, July 2018, Taylor & Francis

    Minos Matsoukas, Dr Theodora Katsila

  56. Variants in TPMT, ITPA, ABCC4 And ABCB1 Genes as Predictors of 6-Mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia

    Article • July 2018, De Gruyter

    Dr Theodora Katsila

  57. Can VEGFA and ICAM1 polymorphisms predict response to bevacizumab?

    Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

    Dr Theodora Katsila

  58. An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients

    Article • Anticancer Research, March 2018, International Institute of Anticancer Research

    Dr Theodora Katsila

  59. The New Age of -omics in Urothelial Cancer – Re-wording Its Diagnosis and Treatment

    Article • EBioMedicine, February 2018, Elsevier

    Dr Theodora Katsila

  60. Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment

    Article • Pharmacogenomics, January 2018, Future Medicine

    Dr Theodora Katsila

  61. Searching for Clinically Relevant Biomarkers in Geriatric Oncology

    Article • BioMed Research International, January 2018, Hindawi Publishing Corporation

    Dr Theodora Katsila, George Patrinos

  62. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis

    Article • OMICS A Journal of Integrative Biology, January 2018, Mary Ann Liebert Inc

    Dr Theodora Katsila

  63. Proteomics and Metabolomics Data Analysis for Translational Medicine

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  64. A Review of Tools to Automatically Infer Chromosomal Positions From dbSNP and HGVS Genetic Variants

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  65. Economic Evaluation and Cost-Effectiveness Analysis of Genomic Medicine Interventions in Developing and Emerging Countries

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  66. Human Genomic Databases in Translational Medicine

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  67. Translating Genomic Information to Rationalize Drug Use

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  68. The Genomic Medicine Alliance: A Global Effort to Facilitate the Introduction of Genomics into Healthcare in Developing Nations

    Article • January 2018, Elsevier

    Dr Theodora Katsila

  69. Advancing Global Precision Medicine: An Overview of Genomic Testing and Counseling Services in Malaysia

    Article • OMICS A Journal of Integrative Biology, December 2017, Mary Ann Liebert Inc

    Dr Theodora Katsila

  70. Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients

    Article • Human Genomics, December 2017, Springer Science + Business Media

    Dr Theodora Katsila

  71. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New “Fast-Second Winner” Strategy

    Article • OMICS A Journal of Integrative Biology, November 2017, Mary Ann Liebert Inc

    Dr Theodora Katsila

  72. Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients

    Article • Human Genomics, October 2017, Springer Science + Business Media

    Dr Theodora Katsila

  73. Cancer Genomics and Public Health

    Article • September 2017, Karger Publishers

    Dr Theodora Katsila

  74. Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping

    Article • The American Journal of Human Genetics, September 2017, Elsevier

    Dr Theodora Katsila

  75. Exploring public genomics data for population pharmacogenomics

    Article • PLOS One, August 2017, PLOS

    Dr Theodora Katsila

  76. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation

    Article • OMICS A Journal of Integrative Biology, August 2017, Mary Ann Liebert Inc

    Minos Matsoukas, Dr Theodora Katsila

  77. Key Pharmacogenomic Considerations for Sickle Cell Disease Patients

    Article • OMICS A Journal of Integrative Biology, June 2017, Mary Ann Liebert Inc

    Dr Theodora Katsila

  78. Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment

    Article • Current Pharmaceutical Design, May 2017, Bentham Science Publishers

    Dr Theodora Katsila

  79. Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

    Article • PLOS One, February 2017, PLOS

    Dr Theodora Katsila

  80. Genomic Medicine in Developing Countries and Resource-Limited Environments

    Article • January 2017, Elsevier

    Professor Diego A Forero, Dr Theodora Katsila

  81. Genomic Databases

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  82. Perspectives for Future DNA Sequencing Techniques and Applications

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  83. Cancer Genomics and Public Health

    Article • Public Health Genomics, January 2017, Karger Publishers

    Dr Theodora Katsila

  84. Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics

    Article • Public Health Genomics, January 2017, Karger Publishers

    Dr Theodora Katsila

  85. Exosomes: A Cancer Theranostics Road Map

    Article • Public Health Genomics, January 2017, Karger Publishers

    Dr Theodora Katsila

  86. Pharmacogenomics in Clinical Care and Drug Discovery

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  87. Low- and Medium-Throughput Variant Detection Methods

    Article • January 2017, Elsevier

    Dr Theodora Katsila

  88. Pharmacogenomics education and research at the Department of Pharmacy, University of Patras, Greece

    Article • Pharmacogenomics, November 2016, Future Medicine

    Dr Theodora Katsila

  89. Correlation of SIN3A genomic variants with β-hemoglobinopathies disease severity and hydroxyurea treatment efficacy

    Article • Pharmacogenomics, November 2016, Future Medicine

    Dr Theodora Katsila

  90. Pharmacometabolomics Informs Viromics toward Precision Medicine

    Article • Frontiers in Pharmacology, October 2016, Frontiers

    Dr Theodora Katsila

  91. Novel genetic risk variants for pediatric celiac disease

    Article • Human Genomics, October 2016, Springer Science + Business Media

    Dr Theodora Katsila

  92. Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies

    Article • Nucleic Acids Research, October 2016, Oxford University Press (OUP)

    Dr Theodora Katsila

  93. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

    Article • PLOS One, September 2016, PLOS

    Dr Theodora Katsila

  94. ePGA: A Web-Based Information System for Translational Pharmacogenomics

    Article • PLOS One, September 2016, PLOS

    Dr Theodora Katsila

  95. Development and validation of a UHPLC-UV method for the determination of a prostate secretory protein 94-derived synthetic peptide (PCK3145) in human plasma and assessment of its stability in human plasma

    Article • Biomedical Chromatography, March 2016, Wiley

    Dr Theodora Katsila

  96. Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease

    Article • EBioMedicine, March 2016, Elsevier

    Dr Theodora Katsila

  97. Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients

    Article • Pharmacogenomics, March 2016, Future Medicine

    Dr Theodora Katsila

  98. Nutrigenomics 2.0: The Need for Ongoing andIndependentEvaluation and Synthesis of Commercial Nutrigenomics Tests' Scientific Knowledge Base for Responsible Innovation

    Article • OMICS A Journal of Integrative Biology, February 2016, Mary Ann Liebert Inc

    Dr Theodora Katsila, Prof. Jean-Christophe Nebel

  99. Allele and genotype frequencies of the two single nucleotide polymorphisms in the VKORC1 gene that are most important for warfarin treatment among Emiratis

    Article • Hamdan Medical Journal, January 2016, Medknow

    Dr Theodora Katsila

  100. Computational approaches in target identification and drug discovery

    Article • Computational and Structural Biotechnology Journal, January 2016, Elsevier

    Dr Theodora Katsila, Minos Matsoukas

  101. Pharmacometabolomics: Applications and Challenges

    Article • Current Pharmacogenomics and Personalized Medicine, December 2015, Bentham Science Publishers

    Dr Theodora Katsila

  102. Functional Analysis of anAγ-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress

    Article • Hemoglobin, November 2015, Taylor & Francis

    Dr Theodora Katsila

  103. Enabling pharmacogenomic services: Informatics and computational discovery aspects

    Article • November 2015, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Theodora Katsila

  104. Identification of a novel homozygous SPG7 mutation by whole exome sequencing in a Greek family with a complicated form of hereditary spastic paraplegia

    Article • European Journal of Medical Genetics, November 2015, Elsevier

    Dr Theodora Katsila

  105. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner

    Article • Pharmacogenomics, October 2015, Future Medicine

    Dr Theodora Katsila

  106. Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics

    Article • Annual Review of Genomics and Human Genetics, September 2015, Annual Reviews

    Dr Theodora Katsila

  107. As solid scientific evidence is lacking, available nutrigenomics tests cannot be recommended

    Article • OMICS A Journal of Integrative Biology, September 2015, Mary Ann Liebert Inc

    Prof. Jean-Christophe Nebel, Dr Theodora Katsila

  108. The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children

    Article • Frontiers in Pediatrics, July 2015, Frontiers

    Dr Theodora Katsila

  109. Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach

    Article • Human Genomics, June 2015, Springer Science + Business Media

    Dr Theodora Katsila

  110. Whole genome sequencing in pharmacogenomics

    Article • Frontiers in Pharmacology, March 2015, Frontiers

    Dr Theodora Katsila

  111. Nutrigenomics: A controversy

    Article • Applied & Translational Genomics, March 2015, Elsevier

    Dr Theodora Katsila

  112. Pharmacogenomics for Haemoglobinopathies Therapeutics

    Article • January 2015, Springer Science + Business Media

    Dr Theodora Katsila

  113. Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer

    Article • Clinical Cancer Research, October 2014, American Association for Cancer Research (AACR)

    Dr Theodora Katsila

  114. Deciphering next-generation pharmacogenomics: an information technology perspective

    Article • Open Biology, July 2014, Royal Society Publishing

    Dr Theodora Katsila, George Patrinos

  115. Enhancing the Biological Relevance of Secretome-Based Proteomics by Linking Tumor Cell Proliferation and Protein Secretion

    Article • Journal of Proteome Research, July 2014, American Chemical Society (ACS)

    Dr Theodora Katsila

  116. Personalized pharmacogenomics profiling using whole-genome sequencing

    Article • Pharmacogenomics, July 2014, Future Medicine

    Dr Theodora Katsila

  117. Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients

    Article • Pharmacogenomics, July 2014, Future Medicine

    Dr Theodora Katsila

  118. Assessment of the Pharmacogenomics Educational Environment in Southeast Europe

    Article • Public Health Genomics, January 2014, Karger Publishers

    Dr Theodora Katsila

  119. DruGeVar: An Online Resource Triangulating Drugs with Genes and Genomic Biomarkers for Clinical Pharmacogenomics

    Article • Public Health Genomics, January 2014, Karger Publishers

    Dr Theodora Katsila

  120. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice

    Article • European Journal of Cancer, May 2013, Elsevier

    Dr Theodora Katsila

  121. Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: Enhanced enzymatic stability and biological properties

    Article • European Journal of Medicinal Chemistry, December 2012, Elsevier

    Dr Theodora Katsila

  122. 1077 Ovarian Malignant Ascites-derived Lymphocytes Stimulated With Prothymosin Alpha or Its Immunoactive Decapeptide Lyse Autologous Tumor Cells in Vitro and Retard Tumor Growth in SCID Mice

    Article • European Journal of Cancer, July 2012, Elsevier

    Dr Theodora Katsila

  123. Peptide and protein drugs: The study of their metabolism and catabolism by mass spectrometry

    Article • Mass Spectrometry Reviews, June 2011, Wiley

    Dr Theodora Katsila

  124. Evaluation of a Stable Gonadotropin-Releasing Hormone Analog in Mice for the Treatment of Endocrine Disorders and Prostate Cancer

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2010, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Theodora Katsila

  125. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    Dr Theodora Katsila

  126. Simultaneous Absolute Quantification of the Glucose-Dependent Insulinotropic Polypeptides GIP1−42and GIP3−42in Mouse Plasma by LC/ESI-MS/MS: Preclinical Evaluation of DP-IV Inhibitors

    Article • Journal of Proteome Research, July 2009, American Chemical Society (ACS)

    Dr Theodora Katsila

  127. In vivoevaluation andin vitrometabolism of leuprolide in mice-mass spectrometry-based biomarker measurement for efficacy and toxicity

    Article • Journal of Mass Spectrometry, October 2008, Wiley

    Dr Theodora Katsila

  128. Evaluation of gonadotropin-releasing hormone analogues in mice – pharmacokinetic studies and biomarker based efficacy by mass spetrometry

    Article • European Journal of Cancer Supplements, July 2008, Elsevier

    Dr Theodora Katsila